These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2970351)

  • 1. Production in vitro of antibodies directed against alloantigen-specific recognition sites on T cells and on lymphocytotoxic HLA antibodies.
    Singal DP; Blajchman MA; Joseph S; Roberge B; Smith EK; Ludwin D
    Clin Exp Immunol; 1988 May; 72(2):222-7. PubMed ID: 2970351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiidiotypic antibodies: production in vitro by EBV-transformed lymphoblastoid cell lines and immunochemical characterization of idiotypic receptors on T-cells.
    Singal DP; Joseph S; Frame B; Ludwin D; Mervart H; Blajchman MA
    Transplant Proc; 1989 Feb; 21(1 Pt 1):333-5. PubMed ID: 2539669
    [No Abstract]   [Full Text] [Related]  

  • 3. Further characterization of IgM antibodies against maternal alloreactive T cells produced by cloned Epstein Barr virus-transformed cord B cells.
    Miyagawa Y
    J Immunol; 1984 Sep; 133(3):1270-7. PubMed ID: 6086753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood B cells producing donor-specific HLA antibodies in vitro.
    Han M; Rogers JA; Lavingia B; Stastny P
    Hum Immunol; 2009 Jan; 70(1):29-34. PubMed ID: 19026703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiotypic network regulations of immune responses to HLA.
    Suciu-Foca N; Rohowsky-Kochan C; Reed E; Haars R; Bonagura V; King DW; Reemstma K
    Fed Proc; 1985 May; 44(8):2483-7. PubMed ID: 3157602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytotoxic antibodies in Israeli patients with rheumatoid arthritis.
    Livneh A; Renert A; Avishai O; Langevitz P; Gazit E
    Isr J Med Sci; 1997 Jan; 33(1):30-5. PubMed ID: 9203515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells.
    Gallagher G; Stimson WH
    Immunology; 1984 Dec; 53(4):611-21. PubMed ID: 6209205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
    Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S
    Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
    Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific anti-donor lymphocytotoxic antibodies following blood transfusion from nonrelated donors.
    Ettenger RB; Jordan SC; Arnett J; Robinson BJ; Fine RN
    Transplant Proc; 1982 Jun; 14(2):347-8. PubMed ID: 7051476
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood transfusions as "transplantation pretreatment": incidence of immunization against unfractionated lymphocytes, T- and B-lymphocytes.
    Fehrman I; Opelz G
    Scand J Urol Nephrol Suppl; 1981; 64():93-9. PubMed ID: 6755690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-HLA antibodies in nephropathic patients].
    Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
    G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiotypic determinants on human T cells and modulation of human T cell responses by anti-idiotypic antibodies.
    Geha RS
    J Immunol; 1984 Oct; 133(4):1846-51. PubMed ID: 6206140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fetus as an allograft: evidence for antiidiotypic antibodies induced by pregnancy.
    Singal DP; Butler L; Liao SK; Joseph S
    Am J Reprod Immunol (1980); 1984 Dec; 6(4):145-51. PubMed ID: 6241427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
    Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of kidney transplant failure and antibodies against MICA.
    Mizutani K; Terasaki P; Bignon JD; Hourmant M; Cesbron-Gautier A; Shih RN; Pei R; Lee J; Ozawa M
    Hum Immunol; 2006 Sep; 67(9):683-91. PubMed ID: 17002898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dilutions and specificity analysis of pretransplant sera.
    Iwaki Y; Terasaki PI; Park MS; Heintz R; Silberman H; Berne T
    Transplant Proc; 1979 Mar; 11(1):944-9. PubMed ID: 377726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
    Majlessi L; Bordenave G
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.